nodes	percent_of_prediction	percent_of_DWPC	metapath
Anidulafungin—Micafungin—COMT—breast cancer	0.0117	0.492	CrCbGaD
Anidulafungin—Caspofungin—SLCO1B1—breast cancer	0.00864	0.363	CrCbGaD
Anidulafungin—Caspofungin—CYP3A4—breast cancer	0.00188	0.079	CrCbGaD
Anidulafungin—Caspofungin—ABCB1—breast cancer	0.00157	0.0658	CrCbGaD
Anidulafungin—Confusional state—Docetaxel—breast cancer	0.000267	0.000273	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000265	0.000272	CcSEcCtD
Anidulafungin—Urinary tract disorder—Methotrexate—breast cancer	0.000265	0.000271	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Epirubicin—breast cancer	0.000264	0.000271	CcSEcCtD
Anidulafungin—Anaphylactic shock—Docetaxel—breast cancer	0.000264	0.000271	CcSEcCtD
Anidulafungin—Pruritus—Gemcitabine—breast cancer	0.000264	0.00027	CcSEcCtD
Anidulafungin—Nausea—Thiotepa—breast cancer	0.000263	0.00027	CcSEcCtD
Anidulafungin—Urethral disorder—Methotrexate—breast cancer	0.000263	0.000269	CcSEcCtD
Anidulafungin—Infection—Docetaxel—breast cancer	0.000263	0.000269	CcSEcCtD
Anidulafungin—Hyperglycaemia—Doxorubicin—breast cancer	0.000262	0.000268	CcSEcCtD
Anidulafungin—Diarrhoea—Irinotecan—breast cancer	0.000262	0.000268	CcSEcCtD
Anidulafungin—Diarrhoea—Mitoxantrone—breast cancer	0.000262	0.000268	CcSEcCtD
Anidulafungin—Pneumonia—Doxorubicin—breast cancer	0.00026	0.000267	CcSEcCtD
Anidulafungin—Nervous system disorder—Docetaxel—breast cancer	0.000259	0.000266	CcSEcCtD
Anidulafungin—Pruritus—Fluorouracil—breast cancer	0.000259	0.000266	CcSEcCtD
Anidulafungin—Thrombocytopenia—Docetaxel—breast cancer	0.000259	0.000265	CcSEcCtD
Anidulafungin—Infestation—Doxorubicin—breast cancer	0.000259	0.000265	CcSEcCtD
Anidulafungin—Infestation NOS—Doxorubicin—breast cancer	0.000259	0.000265	CcSEcCtD
Anidulafungin—Visual impairment—Methotrexate—breast cancer	0.000259	0.000265	CcSEcCtD
Anidulafungin—Confusional state—Capecitabine—breast cancer	0.000258	0.000264	CcSEcCtD
Anidulafungin—Feeling abnormal—Paclitaxel—breast cancer	0.000257	0.000263	CcSEcCtD
Anidulafungin—Skin disorder—Docetaxel—breast cancer	0.000257	0.000263	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Paclitaxel—breast cancer	0.000255	0.000261	CcSEcCtD
Anidulafungin—Diarrhoea—Gemcitabine—breast cancer	0.000255	0.000261	CcSEcCtD
Anidulafungin—Infection—Capecitabine—breast cancer	0.000254	0.000261	CcSEcCtD
Anidulafungin—Dizziness—Irinotecan—breast cancer	0.000253	0.000259	CcSEcCtD
Anidulafungin—Urinary tract infection—Doxorubicin—breast cancer	0.000252	0.000258	CcSEcCtD
Anidulafungin—Nervous system disorder—Capecitabine—breast cancer	0.000251	0.000257	CcSEcCtD
Anidulafungin—Eye disorder—Methotrexate—breast cancer	0.000251	0.000257	CcSEcCtD
Anidulafungin—Diarrhoea—Fluorouracil—breast cancer	0.000251	0.000257	CcSEcCtD
Anidulafungin—Thrombocytopenia—Capecitabine—breast cancer	0.000251	0.000257	CcSEcCtD
Anidulafungin—Cardiac disorder—Methotrexate—breast cancer	0.000249	0.000255	CcSEcCtD
Anidulafungin—Skin disorder—Capecitabine—breast cancer	0.000249	0.000255	CcSEcCtD
Anidulafungin—Urinary tract disorder—Epirubicin—breast cancer	0.000248	0.000254	CcSEcCtD
Anidulafungin—Urticaria—Paclitaxel—breast cancer	0.000248	0.000254	CcSEcCtD
Anidulafungin—Hyperhidrosis—Capecitabine—breast cancer	0.000248	0.000254	CcSEcCtD
Anidulafungin—Oedema peripheral—Epirubicin—breast cancer	0.000247	0.000253	CcSEcCtD
Anidulafungin—Hypotension—Docetaxel—breast cancer	0.000247	0.000253	CcSEcCtD
Anidulafungin—Connective tissue disorder—Epirubicin—breast cancer	0.000247	0.000253	CcSEcCtD
Anidulafungin—Body temperature increased—Paclitaxel—breast cancer	0.000247	0.000253	CcSEcCtD
Anidulafungin—Abdominal pain—Paclitaxel—breast cancer	0.000247	0.000253	CcSEcCtD
Anidulafungin—Urethral disorder—Epirubicin—breast cancer	0.000246	0.000252	CcSEcCtD
Anidulafungin—Hepatobiliary disease—Doxorubicin—breast cancer	0.000245	0.000251	CcSEcCtD
Anidulafungin—Angiopathy—Methotrexate—breast cancer	0.000243	0.000249	CcSEcCtD
Anidulafungin—Vomiting—Mitoxantrone—breast cancer	0.000243	0.000249	CcSEcCtD
Anidulafungin—Vomiting—Irinotecan—breast cancer	0.000243	0.000249	CcSEcCtD
Anidulafungin—Immune system disorder—Methotrexate—breast cancer	0.000242	0.000248	CcSEcCtD
Anidulafungin—Dizziness—Fluorouracil—breast cancer	0.000242	0.000248	CcSEcCtD
Anidulafungin—Visual impairment—Epirubicin—breast cancer	0.000242	0.000248	CcSEcCtD
Anidulafungin—Mediastinal disorder—Methotrexate—breast cancer	0.000242	0.000248	CcSEcCtD
Anidulafungin—Rash—Mitoxantrone—breast cancer	0.000241	0.000247	CcSEcCtD
Anidulafungin—Rash—Irinotecan—breast cancer	0.000241	0.000247	CcSEcCtD
Anidulafungin—Dermatitis—Irinotecan—breast cancer	0.000241	0.000247	CcSEcCtD
Anidulafungin—Dermatitis—Mitoxantrone—breast cancer	0.000241	0.000247	CcSEcCtD
Anidulafungin—Chills—Methotrexate—breast cancer	0.000241	0.000247	CcSEcCtD
Anidulafungin—Headache—Irinotecan—breast cancer	0.00024	0.000245	CcSEcCtD
Anidulafungin—Headache—Mitoxantrone—breast cancer	0.00024	0.000245	CcSEcCtD
Anidulafungin—Hypotension—Capecitabine—breast cancer	0.000239	0.000245	CcSEcCtD
Anidulafungin—Insomnia—Docetaxel—breast cancer	0.000239	0.000245	CcSEcCtD
Anidulafungin—Vomiting—Gemcitabine—breast cancer	0.000237	0.000243	CcSEcCtD
Anidulafungin—Dyspnoea—Docetaxel—breast cancer	0.000236	0.000241	CcSEcCtD
Anidulafungin—Mental disorder—Methotrexate—breast cancer	0.000235	0.000241	CcSEcCtD
Anidulafungin—Rash—Gemcitabine—breast cancer	0.000235	0.000241	CcSEcCtD
Anidulafungin—Dermatitis—Gemcitabine—breast cancer	0.000235	0.00024	CcSEcCtD
Anidulafungin—Eye disorder—Epirubicin—breast cancer	0.000235	0.00024	CcSEcCtD
Anidulafungin—Erythema—Methotrexate—breast cancer	0.000234	0.000239	CcSEcCtD
Anidulafungin—Malnutrition—Methotrexate—breast cancer	0.000234	0.000239	CcSEcCtD
Anidulafungin—Headache—Gemcitabine—breast cancer	0.000233	0.000239	CcSEcCtD
Anidulafungin—Flushing—Epirubicin—breast cancer	0.000233	0.000239	CcSEcCtD
Anidulafungin—Cardiac disorder—Epirubicin—breast cancer	0.000233	0.000239	CcSEcCtD
Anidulafungin—Vomiting—Fluorouracil—breast cancer	0.000233	0.000239	CcSEcCtD
Anidulafungin—Dyspepsia—Docetaxel—breast cancer	0.000233	0.000238	CcSEcCtD
Anidulafungin—Insomnia—Capecitabine—breast cancer	0.000232	0.000237	CcSEcCtD
Anidulafungin—Rash—Fluorouracil—breast cancer	0.000231	0.000237	CcSEcCtD
Anidulafungin—Dermatitis—Fluorouracil—breast cancer	0.000231	0.000236	CcSEcCtD
Anidulafungin—Hypersensitivity—Paclitaxel—breast cancer	0.00023	0.000235	CcSEcCtD
Anidulafungin—Headache—Fluorouracil—breast cancer	0.00023	0.000235	CcSEcCtD
Anidulafungin—Urinary tract disorder—Doxorubicin—breast cancer	0.000229	0.000235	CcSEcCtD
Anidulafungin—Oedema peripheral—Doxorubicin—breast cancer	0.000229	0.000234	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000228	0.000234	CcSEcCtD
Anidulafungin—Connective tissue disorder—Doxorubicin—breast cancer	0.000228	0.000234	CcSEcCtD
Anidulafungin—Dyspnoea—Capecitabine—breast cancer	0.000228	0.000234	CcSEcCtD
Anidulafungin—Angiopathy—Epirubicin—breast cancer	0.000228	0.000233	CcSEcCtD
Anidulafungin—Urethral disorder—Doxorubicin—breast cancer	0.000228	0.000233	CcSEcCtD
Anidulafungin—Nausea—Irinotecan—breast cancer	0.000227	0.000233	CcSEcCtD
Anidulafungin—Nausea—Mitoxantrone—breast cancer	0.000227	0.000233	CcSEcCtD
Anidulafungin—Immune system disorder—Epirubicin—breast cancer	0.000227	0.000232	CcSEcCtD
Anidulafungin—Mediastinal disorder—Epirubicin—breast cancer	0.000226	0.000232	CcSEcCtD
Anidulafungin—Constipation—Docetaxel—breast cancer	0.000226	0.000232	CcSEcCtD
Anidulafungin—Back pain—Methotrexate—breast cancer	0.000226	0.000231	CcSEcCtD
Anidulafungin—Dyspepsia—Capecitabine—breast cancer	0.000225	0.000231	CcSEcCtD
Anidulafungin—Chills—Epirubicin—breast cancer	0.000225	0.000231	CcSEcCtD
Anidulafungin—Visual impairment—Doxorubicin—breast cancer	0.000224	0.000229	CcSEcCtD
Anidulafungin—Nausea—Gemcitabine—breast cancer	0.000221	0.000227	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000221	0.000226	CcSEcCtD
Anidulafungin—Pruritus—Paclitaxel—breast cancer	0.000221	0.000226	CcSEcCtD
Anidulafungin—Vision blurred—Methotrexate—breast cancer	0.00022	0.000225	CcSEcCtD
Anidulafungin—Mental disorder—Epirubicin—breast cancer	0.00022	0.000225	CcSEcCtD
Anidulafungin—Constipation—Capecitabine—breast cancer	0.000219	0.000224	CcSEcCtD
Anidulafungin—Erythema—Epirubicin—breast cancer	0.000219	0.000224	CcSEcCtD
Anidulafungin—Malnutrition—Epirubicin—breast cancer	0.000219	0.000224	CcSEcCtD
Anidulafungin—Feeling abnormal—Docetaxel—breast cancer	0.000218	0.000223	CcSEcCtD
Anidulafungin—Nausea—Fluorouracil—breast cancer	0.000218	0.000223	CcSEcCtD
Anidulafungin—Eye disorder—Doxorubicin—breast cancer	0.000217	0.000222	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Docetaxel—breast cancer	0.000216	0.000222	CcSEcCtD
Anidulafungin—Anaemia—Methotrexate—breast cancer	0.000216	0.000221	CcSEcCtD
Anidulafungin—Flushing—Doxorubicin—breast cancer	0.000216	0.000221	CcSEcCtD
Anidulafungin—Cardiac disorder—Doxorubicin—breast cancer	0.000216	0.000221	CcSEcCtD
Anidulafungin—Diarrhoea—Paclitaxel—breast cancer	0.000213	0.000219	CcSEcCtD
Anidulafungin—Back pain—Epirubicin—breast cancer	0.000211	0.000217	CcSEcCtD
Anidulafungin—Feeling abnormal—Capecitabine—breast cancer	0.000211	0.000216	CcSEcCtD
Anidulafungin—Angiopathy—Doxorubicin—breast cancer	0.000211	0.000216	CcSEcCtD
Anidulafungin—Immune system disorder—Doxorubicin—breast cancer	0.00021	0.000215	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Capecitabine—breast cancer	0.000209	0.000214	CcSEcCtD
Anidulafungin—Mediastinal disorder—Doxorubicin—breast cancer	0.000209	0.000214	CcSEcCtD
Anidulafungin—Abdominal pain—Docetaxel—breast cancer	0.000209	0.000214	CcSEcCtD
Anidulafungin—Body temperature increased—Docetaxel—breast cancer	0.000209	0.000214	CcSEcCtD
Anidulafungin—Leukopenia—Methotrexate—breast cancer	0.000209	0.000214	CcSEcCtD
Anidulafungin—Chills—Doxorubicin—breast cancer	0.000208	0.000214	CcSEcCtD
Anidulafungin—Dizziness—Paclitaxel—breast cancer	0.000206	0.000211	CcSEcCtD
Anidulafungin—Vision blurred—Epirubicin—breast cancer	0.000206	0.000211	CcSEcCtD
Anidulafungin—Cough—Methotrexate—breast cancer	0.000204	0.000209	CcSEcCtD
Anidulafungin—Mental disorder—Doxorubicin—breast cancer	0.000204	0.000208	CcSEcCtD
Anidulafungin—Urticaria—Capecitabine—breast cancer	0.000203	0.000208	CcSEcCtD
Anidulafungin—Body temperature increased—Capecitabine—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Abdominal pain—Capecitabine—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Convulsion—Methotrexate—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Malnutrition—Doxorubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Erythema—Doxorubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Anaemia—Epirubicin—breast cancer	0.000202	0.000207	CcSEcCtD
Anidulafungin—Chest pain—Methotrexate—breast cancer	0.000199	0.000204	CcSEcCtD
Anidulafungin—Vomiting—Paclitaxel—breast cancer	0.000198	0.000203	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000197	0.000202	CcSEcCtD
Anidulafungin—Rash—Paclitaxel—breast cancer	0.000197	0.000202	CcSEcCtD
Anidulafungin—Dermatitis—Paclitaxel—breast cancer	0.000197	0.000201	CcSEcCtD
Anidulafungin—Leukopenia—Epirubicin—breast cancer	0.000196	0.0002	CcSEcCtD
Anidulafungin—Back pain—Doxorubicin—breast cancer	0.000196	0.0002	CcSEcCtD
Anidulafungin—Headache—Paclitaxel—breast cancer	0.000195	0.0002	CcSEcCtD
Anidulafungin—Hypersensitivity—Docetaxel—breast cancer	0.000195	0.0002	CcSEcCtD
Anidulafungin—Confusional state—Methotrexate—breast cancer	0.000192	0.000197	CcSEcCtD
Anidulafungin—Cough—Epirubicin—breast cancer	0.000191	0.000195	CcSEcCtD
Anidulafungin—Anaphylactic shock—Methotrexate—breast cancer	0.000191	0.000195	CcSEcCtD
Anidulafungin—Vision blurred—Doxorubicin—breast cancer	0.000191	0.000195	CcSEcCtD
Anidulafungin—Convulsion—Epirubicin—breast cancer	0.000189	0.000194	CcSEcCtD
Anidulafungin—Infection—Methotrexate—breast cancer	0.000189	0.000194	CcSEcCtD
Anidulafungin—Hypertension—Epirubicin—breast cancer	0.000189	0.000193	CcSEcCtD
Anidulafungin—Hypersensitivity—Capecitabine—breast cancer	0.000189	0.000193	CcSEcCtD
Anidulafungin—Pruritus—Docetaxel—breast cancer	0.000187	0.000192	CcSEcCtD
Anidulafungin—Nervous system disorder—Methotrexate—breast cancer	0.000187	0.000191	CcSEcCtD
Anidulafungin—Anaemia—Doxorubicin—breast cancer	0.000187	0.000191	CcSEcCtD
Anidulafungin—Thrombocytopenia—Methotrexate—breast cancer	0.000187	0.000191	CcSEcCtD
Anidulafungin—Chest pain—Epirubicin—breast cancer	0.000186	0.000191	CcSEcCtD
Anidulafungin—Nausea—Paclitaxel—breast cancer	0.000185	0.00019	CcSEcCtD
Anidulafungin—Skin disorder—Methotrexate—breast cancer	0.000185	0.00019	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000185	0.000189	CcSEcCtD
Anidulafungin—Hyperhidrosis—Methotrexate—breast cancer	0.000184	0.000189	CcSEcCtD
Anidulafungin—Pruritus—Capecitabine—breast cancer	0.000181	0.000186	CcSEcCtD
Anidulafungin—Leukopenia—Doxorubicin—breast cancer	0.000181	0.000185	CcSEcCtD
Anidulafungin—Diarrhoea—Docetaxel—breast cancer	0.000181	0.000185	CcSEcCtD
Anidulafungin—Confusional state—Epirubicin—breast cancer	0.00018	0.000184	CcSEcCtD
Anidulafungin—Anaphylactic shock—Epirubicin—breast cancer	0.000178	0.000183	CcSEcCtD
Anidulafungin—Hypotension—Methotrexate—breast cancer	0.000178	0.000182	CcSEcCtD
Anidulafungin—Infection—Epirubicin—breast cancer	0.000177	0.000182	CcSEcCtD
Anidulafungin—Cough—Doxorubicin—breast cancer	0.000176	0.000181	CcSEcCtD
Anidulafungin—Convulsion—Doxorubicin—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Diarrhoea—Capecitabine—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Nervous system disorder—Epirubicin—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Dizziness—Docetaxel—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Thrombocytopenia—Epirubicin—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Hypertension—Doxorubicin—breast cancer	0.000175	0.000179	CcSEcCtD
Anidulafungin—Skin disorder—Epirubicin—breast cancer	0.000173	0.000177	CcSEcCtD
Anidulafungin—Hyperhidrosis—Epirubicin—breast cancer	0.000172	0.000177	CcSEcCtD
Anidulafungin—Insomnia—Methotrexate—breast cancer	0.000172	0.000177	CcSEcCtD
Anidulafungin—Chest pain—Doxorubicin—breast cancer	0.000172	0.000176	CcSEcCtD
Anidulafungin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000171	0.000175	CcSEcCtD
Anidulafungin—Dyspnoea—Methotrexate—breast cancer	0.00017	0.000174	CcSEcCtD
Anidulafungin—Dizziness—Capecitabine—breast cancer	0.000169	0.000173	CcSEcCtD
Anidulafungin—Vomiting—Docetaxel—breast cancer	0.000168	0.000172	CcSEcCtD
Anidulafungin—Dyspepsia—Methotrexate—breast cancer	0.000168	0.000172	CcSEcCtD
Anidulafungin—Rash—Docetaxel—breast cancer	0.000167	0.000171	CcSEcCtD
Anidulafungin—Hypotension—Epirubicin—breast cancer	0.000167	0.000171	CcSEcCtD
Anidulafungin—Dermatitis—Docetaxel—breast cancer	0.000167	0.000171	CcSEcCtD
Anidulafungin—Confusional state—Doxorubicin—breast cancer	0.000166	0.00017	CcSEcCtD
Anidulafungin—Headache—Docetaxel—breast cancer	0.000166	0.00017	CcSEcCtD
Anidulafungin—Anaphylactic shock—Doxorubicin—breast cancer	0.000165	0.000169	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000165	0.000169	CcSEcCtD
Anidulafungin—Infection—Doxorubicin—breast cancer	0.000164	0.000168	CcSEcCtD
Anidulafungin—Vomiting—Capecitabine—breast cancer	0.000163	0.000167	CcSEcCtD
Anidulafungin—Nervous system disorder—Doxorubicin—breast cancer	0.000162	0.000166	CcSEcCtD
Anidulafungin—Thrombocytopenia—Doxorubicin—breast cancer	0.000162	0.000166	CcSEcCtD
Anidulafungin—Rash—Capecitabine—breast cancer	0.000161	0.000165	CcSEcCtD
Anidulafungin—Insomnia—Epirubicin—breast cancer	0.000161	0.000165	CcSEcCtD
Anidulafungin—Dermatitis—Capecitabine—breast cancer	0.000161	0.000165	CcSEcCtD
Anidulafungin—Headache—Capecitabine—breast cancer	0.00016	0.000164	CcSEcCtD
Anidulafungin—Skin disorder—Doxorubicin—breast cancer	0.00016	0.000164	CcSEcCtD
Anidulafungin—Hyperhidrosis—Doxorubicin—breast cancer	0.00016	0.000163	CcSEcCtD
Anidulafungin—Dyspnoea—Epirubicin—breast cancer	0.000159	0.000163	CcSEcCtD
Anidulafungin—Nausea—Docetaxel—breast cancer	0.000157	0.000161	CcSEcCtD
Anidulafungin—Feeling abnormal—Methotrexate—breast cancer	0.000157	0.000161	CcSEcCtD
Anidulafungin—Dyspepsia—Epirubicin—breast cancer	0.000157	0.000161	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Methotrexate—breast cancer	0.000156	0.00016	CcSEcCtD
Anidulafungin—Hypotension—Doxorubicin—breast cancer	0.000154	0.000158	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000154	0.000158	CcSEcCtD
Anidulafungin—Constipation—Epirubicin—breast cancer	0.000153	0.000156	CcSEcCtD
Anidulafungin—Nausea—Capecitabine—breast cancer	0.000152	0.000156	CcSEcCtD
Anidulafungin—Urticaria—Methotrexate—breast cancer	0.000151	0.000155	CcSEcCtD
Anidulafungin—Abdominal pain—Methotrexate—breast cancer	0.000151	0.000154	CcSEcCtD
Anidulafungin—Body temperature increased—Methotrexate—breast cancer	0.000151	0.000154	CcSEcCtD
Anidulafungin—Insomnia—Doxorubicin—breast cancer	0.000149	0.000153	CcSEcCtD
Anidulafungin—Dyspnoea—Doxorubicin—breast cancer	0.000147	0.000151	CcSEcCtD
Anidulafungin—Feeling abnormal—Epirubicin—breast cancer	0.000147	0.000151	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Epirubicin—breast cancer	0.000146	0.000149	CcSEcCtD
Anidulafungin—Dyspepsia—Doxorubicin—breast cancer	0.000145	0.000149	CcSEcCtD
Anidulafungin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000142	0.000146	CcSEcCtD
Anidulafungin—Urticaria—Epirubicin—breast cancer	0.000142	0.000145	CcSEcCtD
Anidulafungin—Constipation—Doxorubicin—breast cancer	0.000141	0.000145	CcSEcCtD
Anidulafungin—Abdominal pain—Epirubicin—breast cancer	0.000141	0.000144	CcSEcCtD
Anidulafungin—Body temperature increased—Epirubicin—breast cancer	0.000141	0.000144	CcSEcCtD
Anidulafungin—Hypersensitivity—Methotrexate—breast cancer	0.00014	0.000144	CcSEcCtD
Anidulafungin—Feeling abnormal—Doxorubicin—breast cancer	0.000136	0.000139	CcSEcCtD
Anidulafungin—Gastrointestinal pain—Doxorubicin—breast cancer	0.000135	0.000138	CcSEcCtD
Anidulafungin—Pruritus—Methotrexate—breast cancer	0.000135	0.000138	CcSEcCtD
Anidulafungin—Hypersensitivity—Epirubicin—breast cancer	0.000131	0.000135	CcSEcCtD
Anidulafungin—Urticaria—Doxorubicin—breast cancer	0.000131	0.000134	CcSEcCtD
Anidulafungin—Abdominal pain—Doxorubicin—breast cancer	0.00013	0.000134	CcSEcCtD
Anidulafungin—Body temperature increased—Doxorubicin—breast cancer	0.00013	0.000134	CcSEcCtD
Anidulafungin—Diarrhoea—Methotrexate—breast cancer	0.00013	0.000134	CcSEcCtD
Anidulafungin—Pruritus—Epirubicin—breast cancer	0.000126	0.000129	CcSEcCtD
Anidulafungin—Dizziness—Methotrexate—breast cancer	0.000126	0.000129	CcSEcCtD
Anidulafungin—Diarrhoea—Epirubicin—breast cancer	0.000122	0.000125	CcSEcCtD
Anidulafungin—Hypersensitivity—Doxorubicin—breast cancer	0.000122	0.000125	CcSEcCtD
Anidulafungin—Vomiting—Methotrexate—breast cancer	0.000121	0.000124	CcSEcCtD
Anidulafungin—Rash—Methotrexate—breast cancer	0.00012	0.000123	CcSEcCtD
Anidulafungin—Dermatitis—Methotrexate—breast cancer	0.00012	0.000123	CcSEcCtD
Anidulafungin—Headache—Methotrexate—breast cancer	0.000119	0.000122	CcSEcCtD
Anidulafungin—Dizziness—Epirubicin—breast cancer	0.000118	0.000121	CcSEcCtD
Anidulafungin—Pruritus—Doxorubicin—breast cancer	0.000117	0.00012	CcSEcCtD
Anidulafungin—Vomiting—Epirubicin—breast cancer	0.000113	0.000116	CcSEcCtD
Anidulafungin—Nausea—Methotrexate—breast cancer	0.000113	0.000116	CcSEcCtD
Anidulafungin—Diarrhoea—Doxorubicin—breast cancer	0.000113	0.000116	CcSEcCtD
Anidulafungin—Rash—Epirubicin—breast cancer	0.000112	0.000115	CcSEcCtD
Anidulafungin—Dermatitis—Epirubicin—breast cancer	0.000112	0.000115	CcSEcCtD
Anidulafungin—Headache—Epirubicin—breast cancer	0.000112	0.000114	CcSEcCtD
Anidulafungin—Dizziness—Doxorubicin—breast cancer	0.000109	0.000112	CcSEcCtD
Anidulafungin—Nausea—Epirubicin—breast cancer	0.000106	0.000109	CcSEcCtD
Anidulafungin—Vomiting—Doxorubicin—breast cancer	0.000105	0.000107	CcSEcCtD
Anidulafungin—Rash—Doxorubicin—breast cancer	0.000104	0.000107	CcSEcCtD
Anidulafungin—Dermatitis—Doxorubicin—breast cancer	0.000104	0.000106	CcSEcCtD
Anidulafungin—Headache—Doxorubicin—breast cancer	0.000103	0.000106	CcSEcCtD
Anidulafungin—Nausea—Doxorubicin—breast cancer	9.8e-05	0.0001	CcSEcCtD
